Sorafenib in Combination With Locoregional Therapy for Hepatocellular Carcinoma in Patients on the Liver Transplant Waiting List: One Center's Experience

被引：0
|
作者：
Truesdale, Aimee E.
Birkhan, Oscar A.
Shah, Neeral L.
Argo, Curtis K.
Al-Osaimi, Abdullah M.
Caldwell, Stephen H.
Schmitt, Timothy M.
Northup, Patrick G.
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1292
引用
收藏
页码：S222 / S222
页数：1
相关论文
共 50 条
  • [41] A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list
    Toso, Christian
    Dupuis-Lozeron, Elise
    Majno, Pietro
    Berney, Thierry
    Kneteman, Norman M.
    Perneger, Thomas
    Morel, Philippe
    Mentha, Gilles
    Combescure, Christophe
    HEPATOLOGY, 2012, 56 (01) : 149 - 156
  • [42] A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list
    Toso, C.
    Dupuis-Lozeron, E.
    Majno, P.
    Berney, T.
    Kneteman, N.
    Perneger, T.
    Morel, P.
    Mentha, G.
    Combescure, C.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 1 - 2
  • [43] A MODEL FOR DROPOUT ASSESSMENT OF CANDIDATES WITH OR WITHOUT HEPATOCELLULAR CARCINOMA ON A COMMON LIVER TRANSPLANT WAITING LIST
    Toso, C.
    Dupuis-Lozeron, E.
    Majno, P.
    Berney, T.
    Kneteman, N.
    Perneger, T.
    Morel, P.
    Mentha, G.
    Combescure, C.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S95 - S95
  • [44] THE IMPACT OF WAITING LIST ALPHA-FETOPROTEIN CHANGES ON THE OUTCOME OF LIVER TRANSPLANT FOR HEPATOCELLULAR CARCINOMA
    Toso, Christian
    Merani, Shaheed
    Majno, Pietro
    Kneteman, Norman M.
    Berney, Thierry
    Morel, Philippe
    Mentha, Gilles
    TRANSPLANT INTERNATIONAL, 2011, 24 : 2 - 3
  • [45] A MODEL FOR DROPOUT ASSESSMENT OF CANDIDATES WITH OR WITHOUT HEPATOCELLULAR CARCINOMA ON A COMMON LIVER TRANSPLANT WAITING LIST
    Toso, Christian
    Dupuis-Lozeron, Elise
    Majno, Pietro
    Berney, Thierry
    Kneteman, Norman M.
    Perneger, Thomas
    Morel, Philippe
    Mentha, Gilles
    Combescure, Christophe
    SWISS MEDICAL WEEKLY, 2012, 142 : 8S - 8S
  • [46] The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma
    Merani, Shaheed
    Majno, Pietro
    Kneteman, Norman M.
    Berney, Thierry
    Morel, Philippe
    Mentha, Gilles
    Toso, Christian
    JOURNAL OF HEPATOLOGY, 2011, 55 (04) : 814 - 819
  • [47] Sorafenib therapy for hepatocellular carcinoma prior to liver transplant is associated with increased complications after transplant
    Truesdale, Aimee E.
    Caldwell, Stephen H.
    Shah, Neeral L.
    Argo, Curtis K.
    Al-Osaimi, Abdullah M. S.
    Schmitt, Timothy M.
    Northup, Patrick G.
    TRANSPLANT INTERNATIONAL, 2011, 24 (10) : 991 - 998
  • [48] Prospective study of stereotactic body radiation therapy as bridging therapy for hepatocellular carcinoma patients on waiting list for liver transplantation
    Wong, T.
    Lee, V
    Law, A.
    Cui, T.
    Fung, J.
    Sin, S.
    Dai, J.
    Chan, A.
    Chok, K.
    Cheung, T.
    Ng, K.
    Kwan, M.
    Leung, T.
    Lo, C.
    TRANSPLANTATION, 2019, 103 (08) : 4 - 4
  • [49] Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation
    Llovet, JM
    Mas, X
    Aponte, JJ
    Fuster, J
    Navasa, M
    Christensen, E
    Rodés, J
    Bruix, J
    GUT, 2002, 50 (01) : 123 - 128
  • [50] Sorafenib as adjuvant therapy post-liver transplant - a single center experience
    Hassanain, H. S.
    Elaileh, A.
    Patel, K.
    Connor, A. A.
    Abdelrahim, M.
    Kodali, S.
    Basra, T.
    Victor, D. W., III
    Simon, C. J.
    Cheah, Y. L.
    Hobeika, M.
    Mobley, C. M.
    Saharia, A.
    Divatia, M.
    Dhingra, S.
    Schwartz, M.
    Maqsood, A.
    Heyne, K.
    Kaseb, A.
    Vauthey, J. -N.
    Gaber, A. O.
    Ghobrial, R. M.
    LIVER TRANSPLANTATION, 2024, 30 : 240 - 241
12345